🇺🇸 FDA
Patent

US 8389736

Compounds having activity in correcting mutant-CFTR processing and uses thereof

granted A61KA61K31/427A61K31/429

Quick answer

US patent 8389736 (Compounds having activity in correcting mutant-CFTR processing and uses thereof) held by The Regents of the University of California expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/427, A61K31/429, A61K31/53, A61P